Rakovina Therapeutics Inc. (TSXV:RKV)
Canada · Delayed Price · Currency is CAD 0.1100
0.00 (0.00%)
At close: Jul 17, 2026
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 2.69 million as of July 17, 2026. Its market cap has decreased by -81.05% in one year.
Market Cap
2.69M
Enterprise Value
5.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
ChartMarket Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 2.69M, a decrease of -81.95%. That is a compound annual growth rate of -27.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 2.69M | 26.99% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kane Biotech | 5.13M |
| XORTX Therapeutics | 5.11M |
| PharmaTher Holdings | 4.55M |
| Innovotech | 4.36M |
| Quest PharmaTech | 4.23M |
| Grey Matters Health | 3.29M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 2.06M |